Seth Lederman is co-founder, CEO and chairman of Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company dedicated to the development of novel medicines for disorders of the central nervous system, including fibromyalgia, post-traumatic stress disorder (PTSD), and episodic tension-type headache.
December 14, 2022
The importance of collaborative efforts in generating new vaccines to protect a vulnerable world
5 min read
May 5, 2015
If you want to launch a new drug company, you’ll need experience, drive and excellent science… not to mention a great deal of perseverance.
1 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
